Jiangsu Hengrui Medicine Co Ltd (600276)

Currency in CNY
56.05
-0.35(-0.62%)
Closed·
600276 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
55.3256.75
52 wk Range
48.8874.04
Key Statistics
Bid/Ask
56.05 / 56.06
Prev. Close
56.4
Open
56.5
Day's Range
55.32-56.75
52 wk Range
48.88-74.04
Volume
55.78M
Average Volume (3m)
55.87M
1-Year Change
9.6225%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600276 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.50
Upside
+43.62%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Employees
20602
Market
China

Compare 600276 to Peers and Sector

Metrics to compare
600276
Peers
Sector
Relationship
P/E Ratio
45.8x19.8x−0.4x
PEG Ratio
-0.670.00
Price/Book
5.8x1.8x2.6x
Price / LTM Sales
11.4x2.3x3.2x
Upside (Analyst Target)
41.3%21.8%46.2%
Fair Value Upside
Unlock18.8%7.2%Unlock

Analyst Ratings

20 Buy
1 Hold
0 Sell
Ratings:
21 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 80.50
(+43.62% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Buy70.00+24.89%78.00MaintainMar 30, 2026
Nomura/Instinet
Buy72.38+29.13%78.21MaintainFeb 16, 2026
JPMorgan
Buy78.00+39.16%-UpgradeOct 29, 2025
UBS
Buy78.60+40.23%-MaintainSep 29, 2025
JPMorgan
Hold78.00+39.16%69.00MaintainSep 23, 2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
0.35%
Industry Median 1.52%
Annualized payout
0.20
Paid annually
5-Years Growth
+3.71%
Growth Streak

Earnings

Latest Release
Apr 22, 2026
EPS / Forecast
0.34 / 0.32
Revenue / Forecast
8.14B / --
EPS Revisions
Last 90 days

600276 Income Statement

People Also Watch

19.37
603993
+0.05%
133.79
300274
-0.53%
472.70
002371
-0.48%
39.92
603288
+0.86%
100.08
603259
-0.11%

FAQ

What Is the Jiangsu Hengrui (600276) Stock Price Today?

The Jiangsu Hengrui stock price today is 56.05 CNY.

What Stock Exchange Does Jiangsu Hengrui Trade On?

Jiangsu Hengrui is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Jiangsu Hengrui?

The stock symbol for Jiangsu Hengrui is "600276."

Does Jiangsu Hengrui Pay Dividends? What’s The Current Dividend Yield?

The Jiangsu Hengrui dividend yield is 0.35%.

What Is the Jiangsu Hengrui Market Cap?

As of today, Jiangsu Hengrui market cap is 372.15B CNY.

When Is the Next Jiangsu Hengrui Earnings Date?

Jiangsu Hengrui will release its next earnings report on Aug 17, 2026.

From a Technical Analysis Perspective, Is 600276 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Jiangsu Hengrui Stock Split?

Jiangsu Hengrui has split 19 times.

How Many Employees Does Jiangsu Hengrui Have?

Jiangsu Hengrui has 20602 employees.

What is the current trading status of Jiangsu Hengrui (600276)?

As of Apr 26, 2026, Jiangsu Hengrui (600276) is trading at a price of 56.05 CNY, with a previous close of 56.40 CNY. The stock has fluctuated within a day range of 55.32 CNY to 56.75 CNY, while its 52-week range spans from 48.88 CNY to 74.04 CNY.

What Is Jiangsu Hengrui (600276) Price Target According to Analysts?

The average 12-month price target for Jiangsu Hengrui is 80.50 CNY, with a high estimate of 123 CNY and a low estimate of 65 CNY. 20 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +43.62% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.